Are electronic signatures legally valid?

Yes. Electronic signatures are legally binding under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA statutes where adopted; exceptions such as wills or certain court filings remain.

Do patient signatures require special disclosures?

If a consumer-facing record requires consent or financial obligation, provide the ESIGN consumer disclosure and obtain affirmative consent per 15 U.S.C. §7001(c).

Is a HIPAA BAA required for e-signature vendors?

Yes. When PHI is created, maintained, or transmitted, the covered entity must have a Business Associate Agreement with the vendor to meet HIPAA obligations.

Can I use remote online notarization (RON)?

Possibly. Many states permit permanent RON with identity proofing and audio‑video recording; verify your state notary rules before relying on RON for authentication.

How do I correct a completed notification?

Issue an amended notification that references the original, obtain required approvals again, and retain both versions to preserve an audit trail for compliance.

Who must sign the notification?

Signers typically include the responsible clinician, a compliance or privacy officer, and IRB or committee approver where applicable; confirm institutional signature authority policies.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Use Notification

Healthcare Clinical Use Notification

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL USE NOTIFICATION

Notification Date:

Purpose of Notification

This Healthcare Clinical Use Notification documents that the clinical team intends to use a specified medical intervention, device, or pharmaceutical agent for the care of the patient identified below. It provides the patient with information regarding the clinical rationale, anticipated benefits, possible risks, alternatives, regulatory or institutional status of the proposed use, and relevant privacy disclosures. This notification is not a substitute for informed consent where required by law or institutional policy.

Patient Information

Patient Name

Date of Birth:

Gender:

Address

Phone:

Email:

Emergency Contact

Insurance & Responsible Party

Primary Insurance Provider

Policy/ID Number:

Group Number:

Subscriber / Responsible Party

Medical History Summary

Current Medications Allergies (including drug allergies) Prior Surgeries / Hospitalizations Chronic Conditions

Clinical Use Details

Proposed Procedure / Clinical Use Description

Device/Drug Name:

Manufacturer / Source:

Model / Lot / Batch #:

Proposed Start Date:

Intended Clinical Objective:

Use Status: Standard / FDA-labeled use Off-label use Experimental / Investigational

Institutional Oversight: IRB / Ethics Committee approval obtained Reference or Protocol Number:

Risks, Benefits & Alternatives

Summary of Anticipated Benefits: Clinician has documented that the anticipated clinical benefits include the following:

Summary of Material Risks: The following material risks, complications, or uncertainties have been identified as reasonably foreseeable with this proposed use:

Reasonable Alternatives: The following alternative treatments or approaches have been considered and discussed with the patient:

Privacy, Data Use & Authorization

Information Disclosed: This notification may include protected health information necessary to document the clinical rationale and to coordinate care. The information will be used for treatment, care coordination, billing as applicable, and institutional oversight. By signing below, the patient acknowledges receipt of the facility's privacy practices and understands that additional authorization may be required for research-related disclosures or for disclosure to third parties not involved in care.

Patient acknowledges receipt of privacy notice and disclosures: I acknowledge receipt of the facility privacy practices

Authorization Expiration Date (if applicable):

Clinician Attestation

The undersigned clinician attests that the information above accurately reflects the clinical rationale and status of institutional review or regulatory considerations, and that the patient has been provided an opportunity to ask questions.

Clinician / Responsible Provider Name

Role / Title:

Facility / Department:

Contact Phone:

Contact Email:

Patient Acknowledgment

I have received and reviewed the Clinical Use Notification above. I understand the purpose, the anticipated benefits, the material risks and the alternatives described. I have had an opportunity to ask questions and have received answers to my satisfaction. I understand that this notification does not replace any formal informed consent process that may be required for treatment, research, or investigational uses, and that I may withdraw my consent for the proposed clinical use at any time prior to initiation without penalty to ongoing care.

Patient Name:

Signature:

Date:

If signed by guardian or authorized representative, indicate relationship:

Representative printed name (if applicable):

What the Healthcare Clinical Use Notification Is and when it's used

A Healthcare Clinical Use Notification is a formal document that records planned clinical use of an intervention, device, protocol change, or software feature within a healthcare setting. It summarizes intended purpose, patient population, procedures, data handling, oversight requirements, and effective dates so clinical, compliance, and administrative teams share a single, auditable record of intended clinical activity.

Why this notification matters for clinical and regulatory teams

The notification creates a clear, auditable record that supports compliance, risk review, and informed decision-making. It helps coordinate approvals, documents privacy and security obligations, and reduces operational ambiguity before a clinical change is deployed.

Who prepares and who receives this notification

Typical preparers include clinicians and project leads who document the intended clinical use before implementation.

Healthcare providers and clinical leads responsible for patient care and protocol changes.
Compliance, privacy, and risk officers who review HIPAA and regulatory impacts.
Research teams, IRBs, or quality committees that assess study or pilot approvals.

Core sections to include in a professional notification

A complete Healthcare Clinical Use Notification organizes information so reviewers can quickly verify purpose, scope, approvals, and privacy safeguards.

Purpose Statement

Concise explanation of clinical intent and expected benefit, including whether this is research, pilot, or standard-of-care use.

Intended Use

Detailed description of device, software, or intervention, including how it will be used and any indications or contraindications.

Patient Population

Define inclusion/exclusion criteria, age ranges, and anticipated caseload so reviewers understand the affected population.

Protocol Summary

High-level stepwise workflow, monitoring plans, escalation paths, and proposed start/stop dates for the activity.

Data & Privacy

List data elements collected, intended retention, storage location, and whether a HIPAA BAA or authorization is required.

Approvals

Signature lines and dates for responsible clinician, compliance officer, and IRB or other approving body as applicable.

Sequential steps to complete and approve the notification

Follow a staged workflow so reviewers can verify clinical, privacy, and operational readiness before deployment.

01

Prepare Details: Assemble scope, protocol, and data handling statements.
02

Internal Review: Route to compliance and clinical governance for initial feedback.
03

Obtain Approvals: Secure signatures from clinician, compliance officer, and IRB as required.
04

Distribute Record: File final notification to records and notify operational teams of start date.

Where to file and who to send the final notification to

Identify the typical destinations for the executed notification so it becomes part of institutional records and can be retrieved for audits.

Compliance Office: Official record for regulatory and privacy review.
IRB or Quality Committee: If the activity is research or a pilot requiring review.
Clinical Departments: Inform impacted units and operational leads.
Electronic Records: Archive in EHR or document management system for retention.

Typical online workflow settings for digital completion

Configure an electronic workflow that enforces required fields, signer order, authentication, and archival rules.

Field \| Configuration	Field name \| Online setting
Template	Use standardized template with locked required fields
Signers	Sequential routing: clinician → compliance → IRB
Authentication	Email verification with optional SMS code or SSO
Retention	Auto-archive to records for minimum statutory period

Technical considerations for eSubmission and digital signing

Choose a platform that supports secure upload, signer authentication, audit trails, and archival to clinical records.

Formats Supported: PDF, DOCX, and structured templates
Integrations: EHR and cloud storage connectors
Auth Methods: Email, SMS, SSO options

Security and compliance controls to include or verify

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

HIPAA: HIPAA-compliant workflows; BAA required

Audit Trail: Detailed timestamps, IP, and action history

21 CFR Part 11: Compliant options available for FDA-regulated records

SOC 2 / ISO: SOC 2 Type II and ISO 27001 certifications

Accessibility: WCAG 2.0 Level AA support for accessibility

Principal risks and potential consequences of incorrect notification

HIPAA Fines: Civil penalties and corrective action

Operational Delay: Deployment postponed until issues are remediated

Invalid Consent: Patient consents may be legally deficient

Regulatory Sanctions: State licensing or enforcement actions possible

Civil Liability: Malpractice or negligence claims exposure

Data Breach Costs: Notification and remediation expenses

Common mistakes to avoid when preparing the notification

Failing to define the patient population clearly, which creates consent and eligibility confusion during implementation.
Leaving ambiguous data handling instructions, which can lead to noncompliant storage or unauthorized access to PHI.
Using incorrect signatory authority or unsigned approvals, causing delays or invalidation of the notification.
Not verifying state notary or RON rules before execution, which can prevent legal acceptance in certain jurisdictions.

Typical timing considerations and internal deadlines

Establish internal deadlines to allow sufficient time for review, approvals, and any required authorizations before deployment.

Pre-Implementation Notice:

Submit notification per policy, often 14–30 days before go-live.

IRB Review Window:

Allow the IRB or committee the typical review period required by institution.

Privacy Review:

Schedule privacy and BAA checks before approval is finalized.

Signature Deadline:

Set a firm cutoff to avoid partial or unsigned records.

Archival Deadline:

Archive executed notification immediately to meet retention policies.

Real-world examples of clinical notifications and their outcomes

These examples show how organizations documented clinical use and the operational or compliance benefits they achieved.

Fertility Centers of Illinois

Clinic standardized its notification template to document new device use

Streamlined review and sign-off across clinics
Staff report faster approvals and clearer audit trails, enabling consistent patient communication and easier retrieval during audits.

Hospital Pilot Program

A hospital piloted software changes with a dedicated notification form

Routed to IT, compliance, and clinical leads
The unified record reduced rollout errors, clarified data flows, and documented approvals for the institution's medical device committee.

eSignature vendor comparison for Healthcare Clinical Use Notification workflows

Compare baseline pricing and features relevant to healthcare workflows. signNow is listed first per platform ordering rules.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions about validity, signing, and corrections

Answers to common legal and operational questions about executing and managing Healthcare Clinical Use Notifications.

Need help? Contact support

Are electronic signatures legally valid?
Yes. Electronic signatures are legally binding under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA statutes where adopted; exceptions such as wills or certain court filings remain.
Do patient signatures require special disclosures?
If a consumer-facing record requires consent or financial obligation, provide the ESIGN consumer disclosure and obtain affirmative consent per 15 U.S.C. §7001(c).
Is a HIPAA BAA required for e-signature vendors?
Yes. When PHI is created, maintained, or transmitted, the covered entity must have a Business Associate Agreement with the vendor to meet HIPAA obligations.
Can I use remote online notarization (RON)?
Possibly. Many states permit permanent RON with identity proofing and audio‑video recording; verify your state notary rules before relying on RON for authentication.
How do I correct a completed notification?
Issue an amended notification that references the original, obtain required approvals again, and retain both versions to preserve an audit trail for compliance.
Who must sign the notification?
Signers typically include the responsible clinician, a compliance or privacy officer, and IRB or committee approver where applicable; confirm institutional signature authority policies.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now